SEARCH

SEARCH BY CITATION

References

  • Aalfs, C.M., Van Den Berg, H., Barth, P.G. & Hennekam, R.C. (1995) The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia. European Journal of Pediatrics, 154, 304308.
  • Alter, B.P., Baerlocher, G.M., Savage, S.A., Chanock, S.J., Weksler, B.B., Willner, J.P., Peters, J.A., Giri, N. & Lansdorp, P.M. (2007) Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood, 110, 14391447.
  • Armanios, M.Y., Chen, J.J., Cogan, J.D., Alder, J.K., Ingersoll, R.G., Markin, C., Lawson, W.E., Xie, M., Vulto, I., Phillips, J.A., 3rd, Lansdorp, P.M., Greider, C.W. & Loyd, J.E. (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. The New England Journal of Medicine, 356, 13171326.
  • Atkinson, J.C., Harvey, K.E., Domingo, D.L., Trujillo, M.I., Guadagnini, J.P., Gollins, S., Giri, N., Hart, T.C. & Alter, B.P. (2008) Oral and dental phenotype of dyskeratosis congenita. Oral Diseases, 14, 419427.
  • Auluck, A. (2007) Dyskeratosis congenita. Report of a case with literature review. Medicina Oral, Patologia Oral Y Cirugia Bucal, 12, E369E373.
  • Autexier, C. (2008) POT of gold: modeling dyskeratosis congenita in the mouse. Genes & Development, 22, 17311736.
  • Baykal, C., Kavak, A., Gulcan, P. & Buyukbabani, N. (2003) Dyskeratosis congenita associated with three malignancies. Journal of European Academy of Dermatology and Venereology, 17, 216218.
  • Beran, M., Spitzer, G. & Verma, D.S. (1982) Testosterone and synthetic and androgens improve the in vitro survival of human marrow progenitor cells in serum-free suspension cultures. The Journal of Laboratory and Clinical Medicine, 99, 247253.
  • Blasco, M.A. (2007) Telomere length, stem cells and aging. Nature Chemical Biology, 3, 640649.
  • Chan, S.W. & Blackburn, E.H. (2002) New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene, 21, 553563.
  • Chen, L.Y., Liu, D. & Songyang, Z. (2007) Telomere maintenance through spatial control of telomeric proteins. Molecular and Cellular Biology, 27, 58985909.
  • Chiang, Y.J., Hemann, M.T., Hathcock, K.S., Tessarollo, L., Feigenbaum, L., Hahn, W.C. & Hodes, R.J. (2004) Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Molecular and Cellular Biology, 24, 70247031.
  • Colvin, B.T., Baker, H., Hibbin, J.A., Gordon-Smith, E.C. & Gordon, M. (1984) Haemopoietic progenitor cells in dyskeratosis congenita. British Journal of Haematology, 56, 513515.
  • Coman, D., Herbert, A., McGill, J., Lockwood, L. & Hallahan, A. (2008) Unrelated cord blood transplantation in a girl with Hoyeraal-Hreidarsson syndrome. Bone Marrow Transplantation, 42, 293294.
  • Connor, J.M., Gatherer, D., Gray, F.C., Pirrit, L.A. & Affara, N.A. (1986) Assignment of the gene for dyskeratosis congenita to Xq28. Human Genetics, 72, 348351.
  • Cronkhite, J.T., Xing, C., Raghu, G., Chin, K.M., Torres, F., Rosenblatt, R.L. & Garcia, C.K. (2008) Telomere shortening in familial and sporadic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 178, 729737.
  • Dokal, I. (2000) Dyskeratosis congenita in all its forms. British Journal of Haematology, 110, 768779.
  • Dratchman, R.A. & Alter, B.P. (1995) Dyskeratosis congenita. Dermatologic Clinics, 13, 3339.
  • Du, H.Y., Pumbo, E., Ivanovich, J., An, P., Maziarz, R.T., Reiss, U.M., Chirnomas, D., Shimamura, A., Vlachos, A., Lipton, J.M., Goyal, R.K., Goldman, F., Wilson, D.B., Mason, P.J. & Bessler, M. (2009) TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood, 113, 309316.
  • Erduran, E., Hacisalihoglu, S. & Ozoran, Y. (2003) Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin. Journal of Pediatric Hematology and Oncology, 25, 333335.
  • De La Fuente, J. & Dokal, I. (2007) Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatric Transplantation, 11, 584594.
  • Gilson, E. & Geli, V. (2007) How telomeres are replicated. Nature Reviews, 8, 825838.
  • Gu, B.W., Bessler, M. & Mason, P.J. (2008) A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proceedings of the National Academy of Sciences of the United States of America, 105, 1017310178.
  • Heiss, N.S., Knight, S.W., Vulliamy, T.J., Klauck, S.M., Wiemann, S., Mason, P.J., Poustka, A. & Dokal, I. (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genetics, 19, 3238.
  • Herrera, E., Samper, E., Martin-Caballero, J., Flores, J.M., Lee, H.W. & Blasco, M.A. (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. The EMBO Journal, 18, 29502960.
  • Hockemeyer, D., Palm, W., Wang, R.C., Couto, S.S. & De Lange, T. (2008) Engineered telomere degradation models dyskeratosis congenita. Genes & Development, 22, 17731785.
  • Hosseinimehr, S.J., Zakaryaee, V. & Froughizadeh, M. (2006) Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells. Molecular and Cellular Biochemistry, 287, 193199.
  • Hoyeraal, H.M., Lamvik, J. & Moe, P.J. (1970) Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers. Acta Paediatrica Scandinavica, 59, 185191.
  • Hreidarsson, S., Kristjansson, K., Johannesson, G. & Johannsson, J.H. (1988) A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatrica Scandinavica, 77, 773775.
  • Kajtar, P. & Mehes, K. (1994) Bilateral coats retinopathy associated with aplastic anaemia and mild dyskeratotic signs. American Journal of Medical Genetics, 49, 374377.
  • Kim, S.H., Kaminker, P. & Campisi, J. (1999) TIN2, a new regulator of telomere length in human cells. Nature Genetics, 23, 405412.
  • Kim, S.W., Hwang, J.H., Cheon, J.M., Park, N.S., Park, S.E., Park, S.J., Yun, H.J., Kim, S. & Jo, D.Y. (2005) Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro. Journal of Korean Medical Science, 20, 409416.
  • Kirwan, M., Vulliamy, T., Beswick, R., Walne, A.J., Casimir, C. & Dokal, I. (2008a) Circulating haematopoietic progenitors are differentially reduced amongst subtypes of dyskeratosis congenita. British Journal of Haematology, 140, 719722.
  • Kirwan, M., Beswick, R., Vulliamy, T., Nathwani, A.C., Walne, A.J., Casimir, C. & Dokal, I. (2008b) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. British Journal of Haematology, doi: DOI: 10.1111/j.1365-2141.2008.07516.x
  • Knight, S., Vulliamy, T., Copplestone, A., Gluckman, E., Mason, P. & Dokal, I. (1998) Dyskeratosis Congenita (DC) registry: identification of new features of DC. British Journal of Haematology, 103, 990996.
  • Knight, S.W., Heiss, N.S., Vulliamy, T.J., Greschner, S., Stavrides, G., Pai, G.S., Lestringant, G., Varma, N., Mason, P.J., Dokal, I. & Poustka, A. (1999a) X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. American Journal of Human Genetics, 65, 5058.
  • Knight, S.W., Heiss, N.S., Vulliamy, T.J., Aalfs, C.M., McMahon, C., Richmond, P., Jones, A., Hennekam, R.C., Poustka, A., Mason, P.J. & Dokal, I. (1999b) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. British Journal of Haematology, 107, 335339.
  • De Lange, T. (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes & Development, 19, 21002110.
  • Marrone, A., Walne, A., Tamary, H., Masunari, Y., Kirwan, M., Beswick, R., Vulliamy, T. & Dokal, I. (2007) Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood, 110, 41984205.
  • Marsh, J.C., Will, A.J., Hows, J.M., Sartori, P., Darbyshire, P.J., Williamson, P.J., Oscier, D.G., Dexter, T.M. & Testa, N.G. (1992) “Stem cell” origin of the hematopoietic defect in dyskeratosis congenita. Blood, 79, 31383144.
  • Meier, U.T. (2005) The many facets of H/ACA ribonucleoproteins. Chromosoma, 114, 114.
  • Meier, U.T. (2006) How a single protein complex accommodates many different H/ACA RNAs. Trends in Biochemical Sciences, 31, 311315.
  • Mitchell, J.R., Wood, E. & Collins, K. (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature, 402, 551555.
  • O’Connor, M.S., Safari, A., Xin, H., Liu, D. & Songyang, Z. (2006) A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proceedings of the National Academy of Sciences of the United States of America, 103, 1187411879.
  • Ostronoff, F., Ostronoff, M., Calixto, R., Florencio, R., Domingues, M.C., Souto Maior, A.P., Sucupira, A. & Tagliari, C. (2007) Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure. Biology of Blood and Marrow Transplantation, 13, 366368.
  • Podlevsky, J.D., Bley, C.J., Omana, R.V., Qi, X. & Chen, J.J. (2008) The telomerase database. Nucleic Acids Research, 36, D339D343.
  • Revesz, T., Fletcher, S., Al-Gazali, L.I. & DeBuse, P. (1992) Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? Journal of Medical Genetics, 29, 673675.
  • Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P.H., Cordon-Cardo, C. & Pandolfi, P.P. (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science, 299, 259262.
  • Savage, S.A. & Alter, B.P. (2008) The role of telomere biology in bone marrow failure and other disorders. Mechanisms of Ageing and Development, 129, 3547.
  • Savage, S.A., Giri, N., Baerlocher, G.M., Orr, N., Lansdorp, P.M. & Alter, B.P. (2008) TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. American Journal of Human Genetics, 82, 501509.
  • Tsakiri, K.D., Cronkhite, J.T., Kuan, P.J., Xing, C., Raghu, G., Weissler, J.C., Rosenblatt, R.L., Shay, J.W. & Garcia, C.K. (2007) Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proceedings of the National Academy of Sciences of the United States of America, 104, 75527557.
  • Vulliamy, T.J., Knight, S.W., Dokal, I. & Mason, P.J. (1997) Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood, 90, 22132216.
  • Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P.J. & Dokal, I. (2001a) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature, 413, 432435.
  • Vulliamy, T.J., Knight, S.W., Mason, P.J. & Dokal, I. (2001b) Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Molecules and Diseases, 27, 353357.
  • Vulliamy, T., Marrone, A., Dokal, I. & Mason, P.J. (2002) Association between aplastic anaemia and mutations in telomerase RNA. Lancet, 359, 21682170.
  • Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P.J. & Dokal, I. (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nature Genetics, 36, 447449.
  • Vulliamy, T.J., Walne, A., Baskaradas, A., Mason, P.J., Marrone, A. & Dokal, I. (2005) Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Molecules and Diseases, 34, 257263.
  • Vulliamy, T.J., Marrone, A., Knight, S.W., Walne, A., Mason, P.J. & Dokal, I. (2006) Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood, 107, 26802685.
  • Vulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A. & Dokal, I. (2008) Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proceedings of the National Academy of Sciences of the United States of America, 105, 80738078.
  • Walne, A.J. & Dokal, I. (2008) Dyskeratosis Congenita: a historical perspective. Mechanisms of Ageing and Development, 129, 4859.
  • Walne, A.J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.H., Aljurf, M. & Dokal, I. (2007) Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Human Molecular Genetics, 16, 16191629.
  • Walne, A.J., Vulliamy, T., Beswick, R., Kirwan, M. & Dokal, I. (2008) TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood, 112, 35943600.
  • Yamaguchi, H., Baerlocher, G.M., Lansdorp, P.M., Chanock, S.J., Nunez, O., Sloand, E. & Young, N.S. (2003) Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood, 102, 916918.
  • Yamaguchi, H., Calado, R.T., Ly, H., Kajigaya, S., Baerlocher, G.M., Chanock, S.J., Lansdorp, P.M. & Young, N.S. (2005) Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. The New England Journal of Medicine, 352, 14131424.
  • Ye, J.Z., Donigian, J.R., Van Overbeek, M., Loayza, D., Luo, Y., Krutchinsky, A.N., Chait, B.T. & De Lange, T. (2004) TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. The Journal of Biological Chemistry, 279, 4726447271.
  • Zinsser, F. (1910) Atrophia cutis reticularis cum pigmentations, dystrophia unguium et leukoplakis oris (poikioodermia atrophicans vascularis jacobi). Ikonographia Dermatologica, 5, 219223.